Kvantify is building a quantum-ready drug discovery platform. The team aims to develop top-tier B2B software for drug discovery, utilizing quantum computing to enhance processes like docking, binding affinity, and unbinding kinetics.
The platform is designed to significantly accelerate the drug discovery process by improving the efficiency and accuracy of in-silico simulation testing, enabling the rapid creation and evaluation of different potential drugs. This approach reduces the timeline for drug development and addresses major causes of failure in drug discovery.
Why we invested
We have been following the Kvantify team for almost 2 years, and have always been extremely impressed by their complementarity and deep domain expertise. We are teaming up with a talented group of quantum experts and we see a great match with our B2B software and SaaS expertise and network. We are more than ready to support the team in building the solutions of the future.